This is an HTML version of an attachment to the Official Information request 'Estimating the number of people prescribed PrEP'.


11 June 2021
Bianca Sepulveda
Via Email: [FYI request #15323 email]
Dear Bianca
REQUEST FOR INFORMATION: SPECIAL AUTHORITY APPLICATIONS APPROVED 
FOR EMTRICITABINE WITH TENOFOVIR DISOPROXIL ONLY

Thank you for your request dated 25 May 2021 under the Official Information Act 1982 (OIA) 
for information relating to Special Authority applications for emtricitabine with tenofovir 
disoproxil only. You requested:
The number of approved Special Authority applications (both initial and renewal 
applications) of emtricitabine with tenofovir disoproxil for the use of pre-exposure 
prophylaxis (PrEP), for any recent time frame... eg 2020. In particular:

 at a national level
 in the Wellington (CCDHB) region
Please find the information requested provided within the tables below. Please note, these 
numbers represent the number of approved applications each month, not the number of 
people being dispensed the medicine each month.
Additionally, we have provided a copy of the source data used to generate these tables. The 
source data includes a monthly breakdown by DHB of all initial and renewal applications 
approved in the calendar years 2019 and 2020. 
We trust that this information answers your queries. We are making our information more 
freely available, so we now publish selected OIA responses (excluding personal details) on 
our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services
2020-21-148; A1495517

Table 1: National Special Authority applications approved for emtricitabine with 
tenofovir disoproxil only

2019
2020
Month
Initial Renewal Initial Renewal
January
114
304
83
425
February
130
309
105
477
March
158
364
81
456
April
114
370
20
97
May
149
418
57
406
June
128
375
114
541
July
142
419
113
381
August
117
390
85
415
September
110
402
84
548
October
106
438
94
431
November
118
465
87
511
December
96
453
70
608
National total
1,482
4,707
993
5,296
Table 2: Capital and Coast DHB (CCDHB) Special Authority applications approved for 
emtricitabine with tenofovir disoproxil only

2019
2020
Month
Initial Renewal Initial Renewal
January
12
42
14
42
February
17
49
14
60
March
23
42
13
51
April
14
51
3
10
May
13
67
4
38
June
11
48
15
62
July
18
50
17
57
August
18
54
12
56
September
14
54
11
70
October
12
51
14
55
November
17
76
6
54
December
11
64
14
75
CCDHB total
180
648
137
630
2020-21-148; A1495517
qA58996
2

Document Outline